Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Monti

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Frontiers in Pharmacology|April 21, 2017
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver DiseasesCarmen Festa, Simona De Marino, Adriana Carino, et al.
La Clinica Terapeutica|July 8, 2014
[Urban individual exposure to cadmium and baroreceptor response to posture]A Sancini, F Sinibaldi, B Loreti, et al.
Biomed Research International|March 20, 2013
Targeting the immunogenetic diseases with the appropriate HLA molecular typing: critical appraisal on 2666 patients typed in one single centreM Guarene, C Capittini, A De Silvestri, et al.
Brain Sciences|August 26, 2023
Subacute Partially Reversible Leukoencephalopathy Expands the Aicardi-Goutières Syndrome PhenotypeIsabella Peixoto de Barcelos, Clarissa Bueno, Luís Filipe S Godoy, et al.
International Journal of Oncology|March 10, 2006
Mutant p53 protein in serum could be used as a molecular marker in human breast cancerG A Balogh, D A Mailo, M M Corte, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Frontiers in Pharmacology|April 21, 2017
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver DiseasesCarmen Festa, Simona De Marino, Adriana Carino, et al.
La Clinica Terapeutica|July 8, 2014
[Urban individual exposure to cadmium and baroreceptor response to posture]A Sancini, F Sinibaldi, B Loreti, et al.
Biomed Research International|March 20, 2013
Targeting the immunogenetic diseases with the appropriate HLA molecular typing: critical appraisal on 2666 patients typed in one single centreM Guarene, C Capittini, A De Silvestri, et al.
Brain Sciences|August 26, 2023
Subacute Partially Reversible Leukoencephalopathy Expands the Aicardi-Goutières Syndrome PhenotypeIsabella Peixoto de Barcelos, Clarissa Bueno, Luís Filipe S Godoy, et al.
International Journal of Oncology|March 10, 2006
Mutant p53 protein in serum could be used as a molecular marker in human breast cancerG A Balogh, D A Mailo, M M Corte, et al.
Pageof 14